Global Blood Preparation Market Size By Type (Whole Blood, Blood Components), By Application (Thrombocytosis, Pulmonary Embolism), By Region, And Segment Forecasts, 2023 to 2032

The Global Blood Preparation Market was valued at USD 48.3 billion in 2023 and is projected to reach USD 84.7 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The market’s growth is driven by the rising prevalence of chronic diseases, increasing demand for blood-derived therapeutics, and technological advancements in blood component separation and storage. Rising awareness about blood donation, expanding healthcare infrastructure in emerging markets, and supportive government initiatives are further propelling market expansion.

Drivers:

1. Increasing Prevalence of Chronic and Lifestyle Diseases:

Conditions such as cancer, hemophilia, and cardiovascular diseases require regular blood transfusions and related therapies, which boost the demand for blood preparation products including plasma-derived proteins and whole blood components.

2. Growing Demand for Plasma-Derived Products:

Therapies based on albumin, immunoglobulins, and clotting factors are seeing increased usage in treatment protocols, fueling market demand.

3. Technological Innovations in Blood Collection and Processing:

Automation in blood preparation, cold chain logistics, and high-throughput testing systems are enhancing the safety and efficiency of blood handling, encouraging healthcare institutions to adopt advanced solutions.

Restraints:

1. Risk of Contamination and Transmission of Infections:

Despite rigorous screening, concerns about blood-borne infections and contamination risks remain a significant challenge.

2. Stringent Regulatory Requirements:

The blood preparation industry is highly regulated, and adhering to evolving standards increases development time and cost for market players.

Opportunity:

1. Expanding Use of Recombinant Therapeutics:

The growing adoption of recombinant technologies to produce safer alternatives to plasma-derived products presents significant growth opportunities.

2. Emerging Markets in Asia-Pacific and Latin America:

Countries like India, China, and Brazil are witnessing improved healthcare access and growing awareness regarding blood donation, contributing to market expansion.

Market by System Type Insights:

The Blood Components segment dominated the market in 2023, driven by the increasing use of red blood cells, platelets, and plasma in surgeries and chronic disease management. Within this segment, plasma-derived products held the highest share due to their extensive application in treating immunodeficiencies and hemophilia.

The Whole Blood Collection segment is also expected to grow steadily, supported by advancements in automated collection technologies and rising voluntary blood donation rates globally.

Market by End-use Insights:

Hospitals emerged as the leading end-user segment in 2023, accounting for the majority market share due to their integral role in surgeries, emergency care, and chronic disease management. The Blood Banks segment is also experiencing significant growth, particularly in developed nations where blood component therapy is becoming standard practice.

Market by Regional Insights:

North America held the largest share in the global blood preparation market in 2023, supported by robust healthcare infrastructure, high disease prevalence, and significant government support for blood donation drives. Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by rising healthcare expenditure, growing awareness, and increased investments in healthcare infrastructure.

Competitive Scenario:

Prominent players in the Global Blood Preparation Market include Grifols S.A., CSL Behring, Baxter International Inc., Octapharma AG, Kedrion S.p.A., B. Braun Melsungen AG, Terumo Corporation, Macopharma, Fresenius Kabi, and Bio Products Laboratory Ltd. These companies are investing in R&D, forming strategic collaborations, and expanding their plasma collection networks to meet growing demand.

Scope of Work – Global Blood Preparation Market

Key Market Developments:

2023: Grifols expanded its plasma collection centers across the U.S. to meet rising demand for plasma-derived therapies.

2024: Baxter launched an advanced apheresis device, improving the efficiency of plasma and platelet separation.

2025: CSL Behring entered into a partnership with a biotech firm to co-develop recombinant coagulation factors for hemophilia treatment.

FAQs:

1. What is the current market size of the Global Blood Preparation Market?

The market was valued at USD 48.3 billion in 2023.

2. What is the major growth driver of the Global Blood Preparation Market?

The rising prevalence of chronic diseases and the growing demand for plasma-derived therapies.

3. Which is the largest region during the forecast period in the Global Blood Preparation Market?

North America holds the largest market share due to advanced healthcare infrastructure and robust blood donation systems.

4. Which segment accounted for the largest market share in the Global Blood Preparation Market?

The Blood Components segment, particularly plasma-derived products, accounted for the largest market share.

5. Who are the key market players in the Global Blood Preparation Market?

Grifols S.A., CSL Behring, Baxter International Inc., Octapharma AG, Kedrion S.p.A., and others.